Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 86776 - 86800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Valproic acid	Approved Investigational	CLIP3	25999	downregulated	Valproic Acid results in decreased expression of CLIP3 mRNA	19q13.12	A21037
Valproic acid	Approved Investigational	CLIP3	25999	upregulated	Valproic Acid results in increased expression of CLIP3 mRNA	19q13.12	A24690
Valproic acid	Approved Investigational	CLK1	1195	downregulated	Valproic Acid results in decreased expression of CLK1 mRNA	2q33.1	A21035
Valproic acid	Approved Investigational	CLK4	57396	downregulated	Valproic Acid results in decreased expression of CLK4 mRNA	5q35.3	A24690 A21035
Valproic acid	Approved Investigational	CLMN	79789	upregulated	Valproic Acid results in increased expression of CLMN mRNA	14q32.13	A24691 A24689
Valproic acid	Approved Investigational	CLMP	79827	downregulated	Valproic Acid results in decreased expression of CLMP mRNA	11q24.1	A24691
Valproic acid	Approved Investigational	CLN3	1201	upregulated	Valproic Acid results in increased expression of CLN3 mRNA	16p12.1	A24690
Valproic acid	Approved Investigational	CLN5	1203	downregulated	Valproic Acid results in decreased expression of CLN5 mRNA	13q22.3	A24689
Valproic acid	Approved Investigational	CLN5	1203	upregulated	Valproic Acid results in increased expression of CLN5 mRNA	13q22.3	A24690
Valproic acid	Approved Investigational	CLN8	2055	upregulated	Valproic Acid results in increased expression of CLN8 mRNA	8p23.3	A24691 A24690 A24688 A24689 A21035
Valproic acid	Approved Investigational	CLOCK	9575	downregulated	Valproic Acid results in decreased expression of CLOCK mRNA	4q12	A24690
Valproic acid	Approved Investigational	CLP1	10978	downregulated	Valproic Acid results in decreased expression of CLP1 mRNA	11q12.1	A24690 A24688 A24689
Valproic acid	Approved Investigational	CLPTM1L	81037	upregulated	Valproic Acid results in increased expression of CLPTM1L mRNA	5p15.33	A24690 A21035
Valproic acid	Approved Investigational	CLPX	10845	downregulated	Valproic Acid results in decreased expression of CLPX mRNA	15q22.31	A24690 A21035
Valproic acid	Approved Investigational	CLSTN1	22883	upregulated	Valproic Acid results in increased expression of CLSTN1 mRNA	1p36.22	A24690 A21035
Valproic acid	Approved Investigational	CLSTN2	64084	upregulated	Valproic Acid results in increased expression of CLSTN2 mRNA	3q23	A24690 A24688 A21037
Valproic acid	Approved Investigational	CLTA	1211	upregulated	Valproic Acid results in increased expression of CLTA mRNA	9p13.3	A24690
Valproic acid	Approved Investigational	CLTB	1212	upregulated	Valproic Acid results in increased expression of CLTB mRNA	5q35.2	A24690 A21037
Valproic acid	Approved Investigational	CLU	1191	upregulated	Valproic Acid results in increased expression of CLU mRNA	8p21.1	A24690 A21035
Valproic acid	Approved Investigational	CLUH	23277	upregulated	Valproic Acid results in increased expression of CLUH mRNA	17p13.3	A24690
Valproic acid	Approved Investigational	CLUL1	27098	upregulated	Valproic Acid results in increased expression of CLUL1 mRNA	18p11.32	A24690 A21035
Valproic acid	Approved Investigational	CLVS1	157807	downregulated	Valproic Acid results in decreased expression of CLVS1 mRNA	8q12.2-q12.3	A21037
Valproic acid	Approved Investigational	CLYBL	171425	upregulated	Valproic Acid results in increased expression of CLYBL mRNA	13q32.3	A24691 A24690 A24689 A21037
Valproic acid	Approved Investigational	CMAS	55907	downregulated	Valproic Acid results in decreased expression of CMAS mRNA	12p12.1	A24690
Valproic acid	Approved Investigational	CMBL	134147	downregulated	Valproic Acid results in decreased expression of CMBL mRNA	5p15.2	A24690

Displaying entries 86776 - 86800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability